Differential expression of mutant and normal beta T3 receptor alleles in kindreds with generalized resistance to thyroid hormone.
- 1 May 1993
- journal article
- case report
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 91 (5) , 2296-2300
- https://doi.org/10.1172/jci116458
Abstract
Thyroid hormone resistance (THR) is primarily an autosomal dominant inherited disease characterized by resistance of pituitary and peripheral tissues to the action of thyroid hormone. We investigated whether the heterogeneous phenotypic features that occur not only among kindreds but also within the same kindred might be due to the expression of differing ratios of mutant and normal receptors in tissues. Using an allele-specific primer extension method, we determined the relative expression of normal and mutant mRNAs from the fibroblasts of affected and unaffected members of two kindreds with TRH: A-H and N-N. While two affected members of A-H, as expected, had nearly equal amounts of normal and mutant hTR beta mRNA, two other members had mutant mRNA levels that accounted for at least 70% of the hTR beta mRNA. Phenotypic variability within and between kindreds with generalized resistance to thyroid hormone GRTH may be due to this differential expression of the mutant and wild type mRNA. Furthermore, when several clinical parameters of THR were compared in several affected members from two kindreds with GRTH, we found that two cases in one kindred exhibited a high mutant-to-normal hTR beta ratio and had considerably more bone resistance during their development. In certain kindreds with THR, differing ratios of normal and mutant hTR receptors may be age and growth related and may account for the reported attenuation of phenotypic symptoms with age.Keywords
This publication has 22 references indexed in Scilit:
- Correlations of language abnormalities with localization of mutations in the beta-thyroid hormone receptor in 13 kindreds with generalized resistance to thyroid hormone: identification of four new mutations.Journal of Clinical Endocrinology & Metabolism, 1992
- Expression of apolipoprotein B mRNAs encoding higher- and lower-molecular weight isoproteins in rat liver and intestine.Proceedings of the National Academy of Sciences, 1989
- The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways.Genes & Development, 1989
- Localization of human ERBA2 to the 3p22----3p24.1 region of chromosome 3 and variable deletion in small cell lung cancer.Proceedings of the National Academy of Sciences, 1988
- Identification of a Rat c-erbAα-Related Protein Which Binds Deoxyribonucleic Acid but does not Bind Thyroid HormoneMolecular Endocrinology, 1988
- Alternative splicing generates messages encoding rat c-erbA proteins that do not bind thyroid hormone.Proceedings of the National Academy of Sciences, 1988
- A point mutation in the last intron responsible for increased expression and transforming activity of the c-Ha-ras oncogeneNature, 1988
- Sequences that confer β-tubulin autoregulation through modulated mRNA stability reside within exon 1 of a β-tubulin mRNAPublished by Elsevier ,1987
- Familial generalized resistance to thyroid hormones: report of three kindreds and correlation of patterns of affected tissues with the binding of [125I] triiodothyronine to fibroblast nucleiJournal of Endocrinological Investigation, 1986
- Familial Syndrome Combining Deaf-Mutism, Stippled Epiphyses, Goiter and Abnormally High PBI: Possible Target Organ Refractoriness to Thyroid Hormone12Journal of Clinical Endocrinology & Metabolism, 1967